LifeClean International and Lonza Specialty Ingredients entered into a distribution agreement for the commercialization of healthcare disinfectants in selected European countries. The financial details of this agreement were not disclosed.With this, Lonza Specialty Ingredients has become LifeClean’s first strategic industrial partner.

“One of the world's leading chemical companies choosing to distribute our products is an important acknowledgement and validation of our unique and patented chemical technology. LSI's leadership position in the microbial control solution market will be key to our continued growth. The agreement is also an important breakthrough in the healthcare sector, which is one of our priority areas. This distribution agreement is our first strategic industrial partnership and we look forward to building on this collaboration,” Thomas Lööw, CEO, LifeClean International AB, said.

LifeClean’s highly innovative technology complements LSI’s technology portfolio in both the Professional Hygiene and Healthcare environments. Together, the companies can bring new, high level disinfection solutions to highly critical areas such as hospitals, addressing critical viruses and spores in short contact times.

“Our customers in Hygiene are looking for safe, efficacious and fully compliant solutions for infection prevention. In partnership with LifeClean, Lonza Specialty Ingredients extends its Microbial Control Solutions portfolio thanks to a complementary and highly effective disinfection technology. We are excited to provide our customers with an additional, differentiated solution to bring products to market that help make our world healthier,” Frank Stahl, Sr Vice President, Microbial Control Solutions, Lonza Specialty Ingredients, said.